Efficacy and Safety of Azithromycin in Patients With Bronchiolitis Obliterans

Key facts

Sponsor

Claudio Castanos

Principal Investigator

Claudio m Castaños, MD

Hospital de Pediatria "juan P. Garrahan"

Intervention

Azithromycin(drug)

Enrollment

40 enrolled

Eligibility

5-18 years · All sexes

Timeline

2010 – 2011

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Bronchiolitis obliterans

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07535008
  Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
  Fred Hutchinson Cancer Center
• RECRUITINGNCT07522008
  ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms
  Azienda Ospedaliera Brotzu
• RECRUITINGEARLY PHASE1NCT07239895
  Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells
  Regend Therapeutics
• RECRUITINGPHASE4NCT07045155
  Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
  Chinese PLA General Hospital
• RECRUITINGNANCT07008170
  Laparoendoscopic Rendezvous for Concomitant Gall Bladder Stones and Common Bile Duct Stones
  Minia University
• RECRUITINGNANCT07002944
  Pulsed Radiofrequency of Shoulder Individual Nerves Versus Brachial Plexus in Management of Chronic Post Mastectomy Shoulder Pain
  Cairo University
• ACTIVE NOT RECRUITINGNCT07316829
  TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS
  Fondazione IRCCS Policlinico San Matteo di Pavia
• RECRUITINGPHASE2NCT06476132
  Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
  National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Bronchiolitis obliterans →